Hassard James 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Mar 20, 2024
Insider Transaction Report
Form 4
Hassard James
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2024-03-18$38.14/sh−1,741$66,402→ 29,259 total
Footnotes (1)
- [F1]Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on March 1, 2023. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.